31.3 C
Bangkok
Saturday, May 4, 2024

Company news: Cann Global; Cann Group; InhaleRx; Wellnex Life; Neurotech; MGC Pharma; Stenocare

Cann Global has requested another extension to its voluntary ASX suspension pending the release of a “definitive announcement” on a proposed Thailand acquisition. 

The listed company, which has not traded on the ASX since September 2022, said it has continued to progress “detailed due diligence” on a deal the directors believe to be a “major opportunity” for the company.

Cann Global said it has made submissions to the ASX regarding the proposed transaction and, subject to lodgement of its outstanding financial reports, aims to satisfy the requirements necessary to complete the deal and enable it to resume trading on the ASX.

While not yet in a position to make a “fully detailed acquisition announcement”, Cann Global said it expects to be able to do so by January 31, 2024. 

It added: “It is the board’s view that Thailand is currently one of the…

Read more…

Latest Articles